Swallowable capsule and method for stimulating incretin production within the intestinal tract
AssigneeAlva Therapeutics, Inc.
InventorsMir A. IMRAN, Mir HASHIM, Emily ARNSDORF
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlva Therapeutics, Inc.
InventorsMir A. IMRAN, Mir HASHIM, Emily ARNSDORF
Estimating the term…
Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more component of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.
(canceled)
A system for stimulating incretin-producing cells (IP-cells) in an intestinal tract of a patient to secrete an incretin, the system comprising:
A system for stimulating incretin-producing cells (IP-cells) in an intestinal tract of a patient to secrete an incretin, the system comprising:
Dependencies are inferred from the claim text.